John P. Leonard, M.D.

Medical Oncology
John Leonard

Everything that we do at our center, whether clinical care, research or education, is focused on helping patients.

Here are some of the many reasons why patients tell us they come here - whether from the New York area, the surrounding region, or traveling from all over the country and other parts of the world in order to receive evaluation and treatment for lymphoma by our group:

We are not a "factory" or a "machine", moving patients through as if they are boxes in a warehouse. Instead we provide personalized and compassionate care that is state of the art.  We take the time to get to know our patients, and partner with them to devise the best available evaluation and treatment program.  While we are well aware of "guidelines", "treatment algorithms", and "institutional programs and regimens", we focus on what is best for the individual patient rather than a cookbook.

Patients seek treatment here because they are referred here by their physicians, who recognize our expertise and know that across the region and the country we are a "go to" place to seek the best lymphoma care.  Our physicians are internationally recognized for clinical skill, research, and personal qualities.  In fact, we care for a substantial number of individual physicians (or their family members) who are themselves dealing with lymphoma.  

Cancer patients don't always (or unfortunately won't always) just have cancer - they have multiple other complex medical problems that may be active concurrently with or exacerbated by cancer treatment.  Weill Cornell Medical College physicians are among the best across all medical specialties, not just cancer.  New York Presbyterian Hospital is one of the top hospitals in the nation.  This can be particularly valuable in patients dealing with issues such as cardiology, pediatrics, obstetrics and gynecology, neurology, endocrinology, lung and kidney issues.  Patients do not want to have to be sent to another hospital or center should their other medical issues become a problem in the midst of cancer treatment.  They want access to the best specialists if needed, all in one place, in a coordinated fashion.  

Our center provides access to the full array of resources needed for "comprehensive" cancer care.  This includes nutrition, psychosocial support, complementary medicine, rehabilitation, pain management, and other areas.  We have developed an outstanding team of physicians (including medical oncologists, radiation oncologists, pathologists, and others), nurses, physician assistants and related health care personnel in order to optimally serve patients with these disorders.  Our patients recognize the value of this support.

The hematopathology group (responsible for diagnosing and evaluating biopsies of lymphomas and other blood cancers) is among the best and largest of any academic medical center.  They are widely recognized for their diagnostic and research expertise, and in fact have a significant role in educating other hematopathology specialists.

Weill Cornell Medical College has an outstanding electronic medical record, which facilitates communication among caregivers and also makes information directly available to patients via Weill Cornell Connect.

We are available to our patients.  They appreciate countless late night phone calls and frequent interactions by email when we are needed.

Physicians in our group are tightly connected with and collaborate with lymphoma-related non-profit organizations such as the Lymphoma Research Foundation and Leukemia and Lymphoma Society.  Several have leadership roles with these groups.  They know our team very well.

Our program and our physicians are internationally recognized for efforts to enable patients with non-Hodgkin's lymphoma, Hodgkin's disease and related disorders to have the best possible clinical outcome. We have helped to establish standards of care practiced across the US.  Our group has played a role in development of nearly every drug that has been FDA approved for lymphoma therapy in the last decade. Through clinical trials, many of our patients were among the first in the world to receive them.  We are leaders of the Lymphoma Committee of National Cancer Institute-supported Alliance for Clinical Trials in Oncology within the NCI's National Clinical Trials Network.  In this capacity, and through the NCI Lymphoma Steering Committee, we lead NCI sponsored trials being conducted at major medical centers across the US that will establish the next generation of therapies.  

We also interact with other leading lymphoma centers across the world - their physicians know us well, mutually share advice and opinions, and appreciate our expertise and collaboration.  Pharmaceutical companies who need help in developing new agents for lymphoma also regularly seek our counsel and participation.

Many patients come here from initial diagnosis because they recognize that we are the place to be for their entire lymphoma journey.  Others come for a second opinion, and return to a local physician - we are happy to provide this service and to remain available for input whenever needed.  Unfortunately, some patients come here because they have few effective treatment possibilities left due to the nature of their disease.  We are committed to making every effort to meet the needs of each patient that turns to us, and in many cases we have new ideas and strategies that can make a significant difference.

Our laboratory collaborators at Weill Cornell include many of the leading lymphoma and cancer researchers in the world.  We are recognized for our translational studies in areas such as immunotherapy, cell cycle inhibitors, tumor profiling, PI3 kinase inhibition, epigenetic therapy, tumor suppressors, and other areas that are at the forefront of lymphoma research.

While a major part of our efforts are focused on trying to bring new and "cutting edge" treatments to patients, we recognize that many patients are not interested in or appropriate for participation in clinical trials.  Our patients recognize and appreciate that we are committed to providing information on all of the options (both standard and new), and partnering with patients and families in order to develop a treatment approach that fits every individual situation.

Lymphomas as a group are a complex set of disorders. While many patients are treated here as their primary oncologist, others come for a second opinion while having their primary oncologic care with a local physician, having us follow along as needed. Others are referred (or otherwise seek care) for access to novel agents as part of clinical trials. We are pleased to provide care in any fashion that would be of assistance to patients, in order to help them achieve the best possible therapeutic results. Patients or physicians with any questions about our lymphoma programs, clinical trials, or related issues should feel free to contact us for more information.

POSITION:

The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology

Professor of Medicine

Vice-Chairman, Department of Medicine

Associate Dean for Clinical Research, Weill Cornell Medical College

Attending Physician, New York Presbyterian Hospital

Director, Joint Clinical Trials Office, Weill Cornell Medical College and New York Presbyterian Hospital

EDUCATION:

M.D. - University of Virginia School of Medicine, 1990

B.A. - Johns Hopkins University, 1986

 

PROFESSIONAL TRAINING:

Fellow, Division of Hematology and Oncology, Department of Medicine, New York Hospital - Cornell Medical Center, 1993 - 1996

Intern and Resident, Department of Medicine, New York Hospital - Cornell Medical Center, 1991-1993

 

PRIOR POSITIONS HELD:

Associate Professor of Medicine, Weill Medical College of Cornell University 2004 - 2007

Assistant Professor of Medicine, Weill Medical College of Cornell University, 1997 - 2004

Chief Resident, Department of Medicine, New York Hospital - Cornell Medical Center, 1996 - 1997

 

HONORS AND AWARDS:

Elected Member, American Society of Clinical Investigation

Elected Member, American Board of Internal Medicine, Hematology Subspecialty Board Committee

Ellen Glesby Cohen Leadership Award, Lymphoma Research Foundation

Incumbent, Richard T. Silver Distinguished Professorship of Hematology and Medical Oncology

Chief Medical Resident, New York Hospital - Cornell Medical Center

Medical Housestaff Program Director's Award, New York Hospital - Cornell Medical Center

Outstanding Medical Student Award, Medical Alumni Association, University of Virginia School of Medicine

Raven Society, University of Virginia

"Top Doctors," New York Metro Area (Castle Connolly Guide) 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2013, 2013, 2014 (New York Magazine)

 

PROFESSIONAL MEMBERSHIPS (PAST OR PRESENT):

Editorial Board, Blood

Editorial Board, Journal of Clinical Oncology

Scientific Editor, Cancer Discovery

American Society of Hematology

American Society of Clinical Oncology

 

SELECTED OTHER PROFESSIONAL RESPONSIBILITIES (PAST OR PRESENT):

Chair, Lymphoma Committee, Alliance for Clinical Trials in Oncology, National Cancer Institute - National Clinical Trials Network

Member, Lymphoma Steering Committee, National Cancer Institute

Member, Hematology Subspecialty Board, American Board of Internal Medicine

Chair, Scientific Advisory Board, Lymphoma Research Foundation

Board Member, Leukemia and Lymphoma Society, New York City Chapter

Member, Government Affairs Committee, American Society of Hematology

Member, Communications Committee, American Society of Hematology

Member, Scientific Committee on Lymphoid Neoplasia, American Society of Hematology

Member, Advisory Committee, International Conference on Lymphoid Malignancies, Lugano Switzerland

Member, Clinical Advisory Committee, World Health Organization Classification of Lymphoid Malignancies

Chair, Hematologic Malignancies Staging System Project 8th Edition, American Joint Commission on Cancer

 

 

INVITED LECTURES:

American Society of Hematology

American Society of Clinical Oncology

European Hematology Association

Japan Society of Hematology

Chemotherapy Foundation Symposium

Society for Biological Therapy

Invited lectures at numerous other national and international meetings/symposia and academic centers including Mayo Clinic, MD Anderson Cancer Center, University of Virginia, Memorial Sloan Kettering Cancer Center, University of North Carolina, Tufts Medical Center, University of Pennsylvania, Beth Israel Deaconess Medical Center

 

Insurances

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [HMO]
  • AETNA [PPO]
  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Insurance Plan of NY (HIP)
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Health Republic
  • Medicaid
  • Medicare
  • Medicare [Medicare]
  • Oscar
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Freedom]
  • POMCO
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]

Publications

Over 130 publications in journals such as Journal of Clinical Oncology, Blood, New England Journal of Medicine, Lancet Oncology, British Journal of Hematology, Leukemia and Lymphoma, Cancer, Cancer Discovery, Clinical Cancer Research

Honors and Awards

HONORS AND AWARDS:

Elected Member, American Society of Clinical Investigation

Elected Member, American Board of Internal Medicine, Hematology Subspecialty Board Committee

Ellen Glesby Cohen Leadership Award, Lymphoma Research Foundation

Incumbent, Richard T. Silver Distinguished Professorship of Hematology and Medical Oncology

Chief Medical Resident, New York Hospital - Cornell Medical Center

Medical Housestaff Program Director's Award, New York Hospital - Cornell Medical Center

Outstanding Medical Student Award, Medical Alumni Association, University of Virginia School of Medicine

Raven Society, University of Virginia

"Top Doctors," New York Metro Area (Castle Connolly Guide) 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2013, 2013, 2014 (New York Magazine)

 

PROFESSIONAL MEMBERSHIPS (PAST OR PRESENT):

Editorial Board, Blood

Editorial Board, Journal of Clinical Oncology

Scientific Editor, Cancer Discovery

American Society of Hematology

American Society of Clinical Oncology

 

SELECTED OTHER PROFESSIONAL RESPONSIBILITIES (PAST OR PRESENT):

Chair, Lymphoma Committee, Alliance for Clinical Trials in Oncology, National Cancer Institute - National Clinical Trials Network

Member, Lymphoma Steering Committee, National Cancer Institute

Member, Hematology Subspecialty Board, American Board of Internal Medicine

Chair, Scientific Advisory Board, Lymphoma Research Foundation

Board Member, Leukemia and Lymphoma Society, New York City Chapter

Member, Government Affairs Committee, American Society of Hematology

Member, Communications Committee, American Society of Hematology

Member, Scientific Committee on Lymphoid Neoplasia, American Society of Hematology

Member, Advisory Committee, International Conference on Lymphoid Malignancies, Lugano Switzerland

Member, Clinical Advisory Committee, World Health Organization Classification of Lymphoid Malignancies

Chair, Hematologic Malignancies Staging System Project 8th Edition, American Joint Commission on Cancer

 

 

INVITED LECTURES:

American Society of Hematology

American Society of Clinical Oncology

European Hematology Association

Japan Society of Hematology

Chemotherapy Foundation Symposium

Society for Biological Therapy

Invited lectures at numerous other national and international meetings/symposia and academic centers including Mayo Clinic, MD Anderson Cancer Center, University of Virginia, Memorial Sloan Kettering Cancer Center, University of North Carolina, Tufts Medical Center, University of Pennsylvania, Beth Israel Deaconess Medical Center